CN111166771A - 一种伤口生肌长皮用中药组合物及其制备方法和应用 - Google Patents
一种伤口生肌长皮用中药组合物及其制备方法和应用 Download PDFInfo
- Publication number
- CN111166771A CN111166771A CN202010061638.1A CN202010061638A CN111166771A CN 111166771 A CN111166771 A CN 111166771A CN 202010061638 A CN202010061638 A CN 202010061638A CN 111166771 A CN111166771 A CN 111166771A
- Authority
- CN
- China
- Prior art keywords
- parts
- tissue regeneration
- wounds
- skin growth
- promoting
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003814 drug Substances 0.000 title claims abstract description 63
- 208000027418 Wounds and injury Diseases 0.000 title claims abstract description 59
- 206010052428 Wound Diseases 0.000 title claims abstract description 52
- 230000001737 promoting effect Effects 0.000 title claims abstract description 34
- 239000000203 mixture Substances 0.000 title claims abstract description 28
- 230000017423 tissue regeneration Effects 0.000 title claims abstract description 27
- 230000008470 skin growth Effects 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title claims abstract description 12
- 239000000843 powder Substances 0.000 claims abstract description 25
- 241000241413 Propolis Species 0.000 claims abstract description 23
- 229940069949 propolis Drugs 0.000 claims abstract description 23
- 210000000988 bone and bone Anatomy 0.000 claims abstract description 15
- 229940037003 alum Drugs 0.000 claims abstract description 13
- 230000017074 necrotic cell death Effects 0.000 claims abstract description 12
- 238000001035 drying Methods 0.000 claims abstract description 11
- 210000003056 antler Anatomy 0.000 claims abstract description 10
- 230000029663 wound healing Effects 0.000 claims abstract description 9
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 238000001354 calcination Methods 0.000 claims abstract description 5
- 238000002156 mixing Methods 0.000 claims abstract description 5
- 238000007873 sieving Methods 0.000 claims abstract description 5
- 238000003756 stirring Methods 0.000 claims abstract description 5
- 244000293323 Cosmos caudatus Species 0.000 claims abstract description 3
- 235000005956 Cosmos caudatus Nutrition 0.000 claims abstract description 3
- 238000010298 pulverizing process Methods 0.000 claims abstract 2
- 206010028851 Necrosis Diseases 0.000 claims description 11
- 206010053615 Thermal burn Diseases 0.000 claims description 9
- 231100000397 ulcer Toxicity 0.000 claims description 9
- 208000015181 infectious disease Diseases 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 5
- 206010017711 Gangrene Diseases 0.000 claims description 5
- 201000010582 ecthyma Diseases 0.000 claims description 5
- 241000283690 Bos taurus Species 0.000 claims description 4
- 208000008960 Diabetic foot Diseases 0.000 claims description 4
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 claims description 4
- 208000004210 Pressure Ulcer Diseases 0.000 claims description 4
- 208000034693 Laceration Diseases 0.000 claims description 3
- 239000003937 drug carrier Substances 0.000 claims description 3
- 239000011812 mixed powder Substances 0.000 claims description 3
- 239000002674 ointment Substances 0.000 claims description 3
- 206010017826 Gastric ulcer haemorrhage Diseases 0.000 claims description 2
- 206010061577 Ulcer haemorrhage Diseases 0.000 claims description 2
- 208000002847 Surgical Wound Diseases 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 abstract description 8
- 208000032843 Hemorrhage Diseases 0.000 abstract description 7
- 230000006378 damage Effects 0.000 abstract description 7
- 208000014674 injury Diseases 0.000 abstract description 7
- 208000007107 Stomach Ulcer Diseases 0.000 abstract description 6
- 201000005917 gastric ulcer Diseases 0.000 abstract description 6
- 230000007547 defect Effects 0.000 abstract description 5
- 210000003205 muscle Anatomy 0.000 abstract description 4
- 208000035143 Bacterial infection Diseases 0.000 abstract description 3
- 208000022362 bacterial infectious disease Diseases 0.000 abstract description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 abstract description 3
- 238000011065 in-situ storage Methods 0.000 abstract description 3
- 230000009471 action Effects 0.000 abstract description 2
- 230000008439 repair process Effects 0.000 abstract description 2
- 238000011282 treatment Methods 0.000 description 15
- 210000004185 liver Anatomy 0.000 description 14
- 239000011049 pearl Substances 0.000 description 10
- 230000035876 healing Effects 0.000 description 9
- 229940126678 chinese medicines Drugs 0.000 description 8
- 208000025865 Ulcer Diseases 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 210000003734 kidney Anatomy 0.000 description 6
- 241000475481 Nebula Species 0.000 description 5
- 230000017531 blood circulation Effects 0.000 description 5
- 229940126680 traditional chinese medicines Drugs 0.000 description 5
- 208000008035 Back Pain Diseases 0.000 description 4
- 208000002193 Pain Diseases 0.000 description 4
- 238000002266 amputation Methods 0.000 description 4
- 235000019606 astringent taste Nutrition 0.000 description 4
- 206010012601 diabetes mellitus Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 238000005469 granulation Methods 0.000 description 4
- 230000003179 granulation Effects 0.000 description 4
- 230000008961 swelling Effects 0.000 description 4
- 208000010392 Bone Fractures Diseases 0.000 description 3
- 206010017076 Fracture Diseases 0.000 description 3
- 206010061218 Inflammation Diseases 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 210000002216 heart Anatomy 0.000 description 3
- 230000004054 inflammatory process Effects 0.000 description 3
- 230000001338 necrotic effect Effects 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- 235000019643 salty taste Nutrition 0.000 description 3
- 231100000331 toxic Toxicity 0.000 description 3
- 230000002588 toxic effect Effects 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- 201000004569 Blindness Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 241000282994 Cervidae Species 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 208000008930 Low Back Pain Diseases 0.000 description 2
- 206010033557 Palpitations Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 206010041497 Spermatorrhoea Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 208000002399 aphthous stomatitis Diseases 0.000 description 2
- 208000019804 backache Diseases 0.000 description 2
- 230000000740 bleeding effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000001914 calming effect Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000001877 deodorizing effect Effects 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 239000012535 impurity Substances 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 238000005096 rolling process Methods 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 235000019605 sweet taste sensations Nutrition 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- 230000037314 wound repair Effects 0.000 description 2
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010057687 Bloody discharge Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 208000003790 Foot Ulcer Diseases 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 206010018852 Haematoma Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000006670 Multiple fractures Diseases 0.000 description 1
- 208000000112 Myalgia Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000002565 Open Fractures Diseases 0.000 description 1
- 208000007117 Oral Ulcer Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 235000007889 Osmunda cinnamomea Nutrition 0.000 description 1
- 244000239204 Plantago lanceolata Species 0.000 description 1
- 235000010503 Plantago lanceolata Nutrition 0.000 description 1
- 206010038084 Rectocele Diseases 0.000 description 1
- 208000036071 Rhinorrhea Diseases 0.000 description 1
- 206010039101 Rhinorrhoea Diseases 0.000 description 1
- 206010039203 Road traffic accident Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- -1 and has antitoxic Substances 0.000 description 1
- 230000001139 anti-pruritic effect Effects 0.000 description 1
- 230000001147 anti-toxic effect Effects 0.000 description 1
- 239000003908 antipruritic agent Substances 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000006399 behavior Effects 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 230000034994 death Effects 0.000 description 1
- 238000001804 debridement Methods 0.000 description 1
- 239000002781 deodorant agent Substances 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000004377 improving vision Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 238000011221 initial treatment Methods 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000002427 irreversible effect Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000002398 materia medica Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 231100000956 nontoxicity Toxicity 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 238000011248 postoperative chemotherapy Methods 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- 230000036560 skin regeneration Effects 0.000 description 1
- 238000002791 soaking Methods 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000002936 tranquilizing effect Effects 0.000 description 1
- 230000000472 traumatic effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/02—Medicinal preparations containing materials or reaction products thereof with undetermined constitution from inanimate materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/618—Molluscs, e.g. fresh-water molluscs, oysters, clams, squids, octopus, cuttlefish, snails or slugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Zoology (AREA)
- Physical Education & Sports Medicine (AREA)
- Dermatology (AREA)
- Oncology (AREA)
- Insects & Arthropods (AREA)
- Communicable Diseases (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Endocrinology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- Marine Sciences & Fisheries (AREA)
- Emergency Medicine (AREA)
- Animal Husbandry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明提供一种伤口生肌长皮用中药组合物及其制备方法和应用,中药组合物包括以下重量份的原料:牛骨20‑50份、珍珠20‑50份、枯矾4‑12份、鹿角20‑50份、蜂胶5‑15份、石决明10‑30份、龙骨10‑20份;制备方法在于,将牛骨、珍珠、枯矾、鹿角、石决明、龙骨煅制、粉碎、过筛后按配比混合得到混合药粉,将蜂胶浸出液加入所述混合药粉后搅拌均匀,干燥后即得;中药组合物可以用于制备促进伤口愈合的药物。本发明外敷可以促使皮肉损伤部位原位生肌长皮愈合,在药物的作用下促进自主修复破损缺损的肌肉和皮肤,从而避免创口细菌感染、组织坏死、组织永久性缺损、功能残障等后果;口服可使胃溃疡、消化道出血短期内治愈。
Description
技术领域
本发明属于伤口修复药物领域,具体涉及一种伤口生肌长皮用中药组合物,另外,本 发明还涉及上述伤口生肌长皮用中药组合物的制备方法和应用。
背景技术
由于生产事故、交通事故、自然灾害、行为不慎造成的开放性骨折、皮肉碾压撕裂坏 死、烧伤、烫伤、胃溃疡、消化道出血、术后刀口脂肪液化裂开、糖尿病患者肢体溃疡、 足趾坏死等患者数量逐年上升,如处置不当,治疗不及时,便会出现创口细菌感染、组织 坏死、组织永久性缺损、功能消失等后果。
目前,对于各种伤口的处理主要以清创、消炎为主,伤口的愈合主要依赖自主愈合, 但是由于患者体质的差异,有的患者的伤口会存在愈合不良,甚至长期难以愈合,功能丧 失或截肢的问题,从而导致患者的治疗疗程延长,费用高,且患者需承受较大的痛苦。
发明内容
基于上述背景问题,本发明旨在提供一种伤口生肌长皮用中药组合物,能够促使皮肉 损伤部位生肌长皮原位再生,从而促进伤口愈合,本发明的另一目的是提供上述伤口生肌 长皮用中药组合物的制备方法和应用。
为达到上述目的,本发明实施例提供的技术方案是:
一种伤口生肌长皮用中药组合物,包括以下重量份的原料:牛骨20-50份、珍珠20-50 份、枯矾4-12份、鹿角20-50份、蜂胶5-15份、石决明10-30份、龙骨10-20份。其中,
牛骨:味甘,性温,无毒。功能主治:治吐血,鼻洪,崩中,带下,肠风,泻血,水 泻,治邪疟。
珍珠:味甘咸、性寒,归心、肝经,安神定惊,清肝明目、解毒生肌;主治:惊悸、 怔仲、心烦失眠、惊风癫痫、目赤翳障、口舌生疮、咽喉溃腐、疮疡久不收口。《本草汇 言》记载可以镇心、定志、安魂、解结毒、化恶疮,将内溃破烂;《本经》记载逢源煅灰 入长内及汤火伤敷之。
枯矾:味涩、酸,性寒,小毒。归肺、脾、肝、大肠经。祛痰燥湿,解毒杀虫,止泻 止血,用于中风,癫痫,喉痹,疥癣湿疮,痈疽肿毒,水火烫伤,口舌生疮,痔疮疼痛, 衄血,脱肛。《医学入门-本草》记载煅后增强收敛,燥湿的作用。
鹿角:味咸,性温,归肾肝经;补肾阳,益精血,强筋骨,行血消肿。用于肾虚腰背 冷痛,阳痿遗精,阴疽疮疡,乳痈肿痛,铁打损伤,筋骨疼痛;《纲目》中记载生用则散 热行血,消肿辟邪,熟用则益肾补虚,强精活血;《附录》中记载能除小腹急瘤,腰背痛, 损伤恶血,益气。
蜂胶:味苦、芳香、略带辛辣。功能与主治:抗毒、杀菌、消炎、镇痛、止痒、除臭、 收敛、生肌。
石决明:味咸,性寒,归肝经,肝清热,明目去翳。用于目赤翳障,视物唇花,青盲 省目。《别录》记载主目障翳痛,青盲,久服益精轻身;《药性论》记载平肝清热,明目 去翳。
龙骨:味涩,归心肝经,为收涩固涩之要药。功能主治:镇静安神,平肝潜阳,收敛固涩,生肌敛疮,用于固涩,金疮出血,自汗盗汗,遗精。抗毒、杀菌、消炎、镇痛、止 痒、除臭、收敛、生肌。
本发明实施例中的各个中药配伍遵从中医药“君、臣、佐、使”之原则,牛骨、珍珠、枯矾为君药,归心、肝、脾、肺大肠经,解毒、收敛、杀虫、生肌;鹿角为臣药,归肾肝 经,补肾阳、行血消肿,生肌长皮;蜂胶为佐药,抗毒、除臭、止痒、收敛、镇痛、生肌; 石决明和龙骨为使药,石决明归肝经,平肝清热;龙骨味涩能敛,入肝经,用于金疮出血。
本发明通过上述中药的配伍,能够促使皮肉缺损部位生肌长皮原位再生,从而促进伤 口自主修复,对坏疽,烧烫伤,开放感染骨折,手术刀口液化症,褥疮,臁疮,糖尿病足,肢体创伤撕裂、坏死、感染、溃疡,胃溃疡,消化道出血均有显著的治疗效果。
为了实现上述目的,本发明实施例还提供上述伤口生肌长皮用中药组合物的制备方法, 将牛骨、珍珠、枯矾、鹿角、石决明、龙骨煅制、粉碎、过筛后按配比混合得到混合药粉, 将蜂胶浸出液物加入所述混合药粉后搅拌均匀,干燥后即得。
优选地,将蜂胶浸泡在酒精中直至溶解完全,过滤后即得蜂胶浸出液。
在一个实施例中,将牛骨、珍珠、枯矾、鹿角、石决明、龙骨粉碎过150-200目筛。
在一个实施例中,干燥温度为50-60℃。
为实现上述目的,一方面,本发明实施例还提供一种上述伤口生肌长皮用中药组合物 在制备促进伤口愈合药物中的用途。
其中,所述伤口包括坏疽,烧烫伤,开放感染骨折,手术刀口液化症,褥疮,臁疮,糖尿病足,肢体创伤撕裂、坏死、感染、溃疡,胃溃疡,消化道出血。
另一方面,本发明实施例还提供一种促进伤口愈合的药物,包括上述的中药组合物、 以及药学上可接受的载体。
其中,所述药物为外敷药物或口服药物。
优选地,所述药物为散剂或膏剂。
与现有技术相比,本发明实施例具有以下效果:
1、本发明实施例能够治疗坏疽、烧烫伤、开放感染骨折、手术刀口液化症、褥疮、臁疮、糖尿病足、胃溃疡及肢体创伤撕裂坏死感染溃疡等症,外敷可以促使皮肉损伤部位原位生肌长皮愈合,在药物的作用下促进自主修复破损缺损的肌肉和皮肤,从而避免创口细菌感染、组织坏死、组织永久性缺损、功能残障等后果,进而解决了其他治疗方法愈合慢,经济负担重,部分患处留有永久缺损及功能障碍,甚至截肢导致不可逆转的残疾。
2、本发明也可口服,口服可使胃溃疡、消化道出血短期内治愈。
3、本发明安全,疗效可靠,使用方法简单,容易掌握,适用广泛;具有疗效快,疗程短的优势。
附图说明
图1为本发明实施例4中典型案例1治疗前后示意图;
图2为本发明实施例4中典型案例3治疗前后示意图;
图3为本发明实施例4中典型案例4治疗前后示意图。
具体实施方式
本发明涉及伤口修复药物领域,提供一种伤口生肌长皮用中药组合物,包括以下重量 份的原料:牛骨20-50份、珍珠20-50份、枯矾4-12份、鹿角20-50份、蜂胶5-15份、石 决明10-30份、龙骨10-20份,本发明通过上述中药的配伍,能够促使皮肉缺损部位生肌长 皮原位再生,从而促进伤口自主修复,对坏疽,烧烫伤,开放感染骨折,手术刀口液化症, 褥疮,臁疮,糖尿病足,肢体创伤撕裂、坏死、感染、溃疡,胃溃疡,消化道出血均有显 著的治疗效果。
接下来将通过具体实施例对本发明进行详细描述。
实施例1
一种伤口生肌长皮用中药组合物,包括以下重量份的原料:牛骨20份、珍珠50份、枯矾4份、鹿角20份、蜂胶15份、石决明10份、龙骨20份。
制备方法包括以下步骤:
(1)称取牛骨20份、珍珠20份、枯矾4份、鹿角20份、蜂胶5份、石决明10份、 龙骨10份,将上述中药清洗、去除杂质后干燥,备用;
(2)分别对上述处理过的中药煅制,具体是将中药放入容器中,高温加热至中药变酥 脆,然后将中药粉碎,过150目筛后得药粉,将药粉混合得混合药粉;
(3)将蜂胶浸泡在酒精中直至溶解完全,溶解时间视蜂胶的溶解度而定,溶解后过滤 得到蜂胶浸出液;
(4)将蜂胶浸出液加入所述混合药粉后搅拌均匀,在50-60℃干燥后即得中药散剂。
实施例2
一种伤口生肌长皮用中药组合物,包括以下重量份的原料:牛骨50份、珍珠20份、枯矾12份、鹿角50份、蜂胶5份、石决明30份、龙骨10份。制备方法包括以下步骤:
(1)称取牛骨50份、珍珠20份、枯矾12份、鹿角50份、蜂胶5份、石决明30份、 龙骨10份,将上述中药清洗、去除杂质后干燥,备用;
(2)分别对上述处理过的中药煅制,具体是将中药放入容器中,高温加热至中药变酥 脆,然后将中药粉碎,过200目筛后得药粉,将药粉混合得混合药粉;
(3)将蜂胶浸出物加入所述混合药粉后搅拌均匀,在50-60℃干燥后即得中药散剂。
实施例3
一种伤口生肌长皮用中药组合物,包括以下重量份的原料:牛骨35份、珍珠30份、枯矾7份、鹿角25份、蜂胶12份、石决明25份、龙骨17份。本实施例的伤口生肌用中 药组合物的制备方法与实施例1的相同。
实施例4
本发明的中药散剂通过外敷患处或内服即可实现治疗。
外敷:将患处进行常规消毒后将本发明中药散剂视患处面积均匀敷于患处,绷带包扎 固定,1至3日换药一次。
口服:对胃溃疡、消化道出血等症实施口服治疗,成人一日2至3次,一次5克,温 开水冲服。
典型案例
(1)高某,女,29岁,剖腹产术10天刀口液化裂开,将实施例3的中药散剂外敷在 伤口处,每日换药一次,15天后愈合,如图1所示,治疗5天后伤口大部分已经愈合,15 天后痊愈。
(2)李某,男,60岁,患双小腿臁疮,患病6年不愈,双小腿呈黑色,溃疡面积较大,皮肤坚硬,将实施例3的中药散剂外敷在伤口处,3日换药一次,60天后痊愈。
(3)肖某,男,54岁,卷板机碾压右足,造成脱 套伤、多发性骨折,糖尿病史10年,经某三甲医院住院治疗13天,右足呈黑色干枯缺血 坏死,院方建议截肢。使用本发明产品结合活血化瘀,通经活络,清热解毒,局部湿疗法, 保护肌肉组织再生愈合。治疗120天康复练习,1年后能自主行走,能从事力所能及的农活, 治疗效果如图2所示。
(4)王某,男,58岁,糖尿病史10年,不慎右手被搅拌机致伤,在某医院创口缝合 治疗一个月,患者手红肿,创口大面积坏死,经无损伤处置清除坏死组织后,将实施例3 的中药散剂外敷在伤口处,2日换药一次,45天痊愈,如图3所示,从左至右依次是治疗 前、治疗初期、治疗后期以及痊愈后的伤口示意图。
(5)王某,男,62岁,直肠术后化疗致手指末端溃疡,将实施例3的中药散剂外敷在伤口处,2日换药一次,15天痊愈。
(6)宋某,男,50岁,糖尿病合并左足坏疽,足底肌肉、肌腱完全坏死,某三甲医院医生确诊告知截肢。将实施例3的中药散剂外敷在伤口处,2日换药一次,80天后,左足 溃疡面生肌长皮可落地行走。
(7)李某,女,30岁,剖宫产术后刀口脂肪液化裂开不愈,刀口长约10cm,将实施 例3的中药散剂外敷在伤口处,每日换药一次,30天后刀口完全愈合。
(8)樊某,男,46岁,因车祸右耳、面部大面积烫伤坏死,左手大面积烫伤坏死,右侧肩胛部大面积烫伤,将实施例3的中药散剂外敷在伤口处,3日换药一次,30天后痊愈。
需要说明的是,本发明的中药组合物可以和药学上可接受的载体制成用于促进伤口愈 合的药物,药物可以外敷也可内服,药物还可以是膏剂,但并不局限于此。
应当指出,对于本领域的普通技术人员来说,在不脱离本发明创造构思的前提下,还 可以做出若干剂量和改进,这些都属于本发明的保护范围。
Claims (10)
1.一种伤口生肌长皮用中药组合物,其特征在于,包括以下重量份的原料:
牛骨20-50份、珍珠20-50份、枯矾4-12份、鹿角20-50份、蜂胶5-15份、石决明10-30份、龙骨10-20份。
2.一种如权利要求1所述的伤口生肌长皮用中药组合物的制备方法,其特征在于,将牛骨、珍珠、枯矾、鹿角、石决明、龙骨煅制、粉碎、过筛后按配比混合得到混合药粉,将蜂胶浸出液加入所述混合药粉后搅拌均匀,干燥后即得中药组合物。
3.根据权利要求2所述的伤口生肌长皮用中药组合物的制备方法,其特征在于,将蜂胶浸泡在酒精中直至溶解完全,过滤后即得蜂胶浸出液。
4.根据权利要求2所述的伤口生肌长皮用中药组合物的制备方法,其特征在于,将牛骨、珍珠、枯矾、鹿角、石决明、龙骨粉碎过150-200目筛。
5.根据权利要求2所述的伤口生肌长皮用中药组合物的制备方法,其特征在于,干燥温度为50-60℃。
6.一种如权利要求1所述的伤口生肌长皮用中药组合物在制备促进伤口愈合药物中的应用。
7.根据权利要求6所述的伤口生肌长皮用中药组合物的应用,其特征在于,所述伤口包括坏疽,烧烫伤,开放感染骨折,手术刀口液化症,褥疮,臁疮,糖尿病足,肢体创伤撕裂、坏死、感染、溃疡,胃溃疡,消化道出血。
8.一种促进伤口愈合的药物,其特征在于,包括权利要求1所述的中药组合物、以及药学上可接受的载体。
9.根据权利要求8所述的促进伤口愈合的药物,其特征在于,所述药物为外敷药物或口服药物。
10.根据权利要求8所述的促进伤口愈合的药物,其特征在于,所述药物为散剂或膏剂。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010061638.1A CN111166771A (zh) | 2020-01-19 | 2020-01-19 | 一种伤口生肌长皮用中药组合物及其制备方法和应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202010061638.1A CN111166771A (zh) | 2020-01-19 | 2020-01-19 | 一种伤口生肌长皮用中药组合物及其制备方法和应用 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111166771A true CN111166771A (zh) | 2020-05-19 |
Family
ID=70624650
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010061638.1A Withdrawn CN111166771A (zh) | 2020-01-19 | 2020-01-19 | 一种伤口生肌长皮用中药组合物及其制备方法和应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN111166771A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112294864A (zh) * | 2020-09-03 | 2021-02-02 | 李菁 | 一种治疗压疮的组合物及其制备方法 |
-
2020
- 2020-01-19 CN CN202010061638.1A patent/CN111166771A/zh not_active Withdrawn
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112294864A (zh) * | 2020-09-03 | 2021-02-02 | 李菁 | 一种治疗压疮的组合物及其制备方法 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100434109C (zh) | 一种治疗烧烫伤的药膏及其制造方法 | |
CN107375708A (zh) | 一种外伤中药 | |
CN111166771A (zh) | 一种伤口生肌长皮用中药组合物及其制备方法和应用 | |
CN110227117A (zh) | 一种治疗骨质增生、腰腿疼痛的药物组合物及其制备方法 | |
CN101332271A (zh) | 一种治疗烧烫伤的外用药物组合物 | |
CN110075258A (zh) | 一种糖尿病足溃疡外用药 | |
CN108310160A (zh) | 一种治疗褥疮的中药组合物 | |
CN113262264A (zh) | 一种用于止痛生肌的中药组合物及其制备方法 | |
CN102784355B (zh) | 急救药及其制备方法 | |
CN102284006B (zh) | 一种治疗褥疮及烧烫创伤的外用膏剂 | |
CN104225245B (zh) | 治疗淋巴结核的中药组合物 | |
CN110393764A (zh) | 一种治疗筋骨疼痛的药酒及其制备方法 | |
CN108653588A (zh) | 一种治疗骨科疾病的外敷中药 | |
CN104083421A (zh) | 治疗褥疮的中药药膏及其制备方法 | |
CN103251724A (zh) | 一种治疗骨伤的外敷膏药及其制备方法 | |
CN101502611B (zh) | 一种治疗癌症药物及其制备方法 | |
CN104688936A (zh) | 一种治疗烧烫伤的中药组合物及其制剂 | |
CN115487229A (zh) | 一种治疗面瘫的药物及其制备方法 | |
CN104587093A (zh) | 一种治疗急性软组织损伤的外用中药散剂 | |
CN104873673A (zh) | 一种治疗骨性关节炎的膏药及制备方法 | |
CN111671838A (zh) | 一种接骨药 | |
CN116870109A (zh) | 一种消肿止痛药酒及其制备方法 | |
CN118203629A (zh) | 一种通经活络消炎的外用膏药及其制备方法 | |
CN117298187A (zh) | 一种治疗烧烫伤以及外伤所致的创伤的药物 | |
CN107648275A (zh) | 一种生肌长皮的中药散剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WW01 | Invention patent application withdrawn after publication |
Application publication date: 20200519 |
|
WW01 | Invention patent application withdrawn after publication |